OTC Watch

All stocks / CVSI

CV Sciences, Inc. CVSI

CV Sciences (CVSI): shares outstanding up 31% in a year and the latest annual figures in plain language. Each fact links to its SEC filing.

DilutionEstimated float OTCQBCalifornia, USA
Live quote on OTC Markets

Market listing

Full name
CV SCIENCES INC
Market tier
OTCQB
Trading status
Active
Last trade
Nov 16
Website
cvsciences.com
Source: Stockwatch, 2026-11-17

News headlines

CV Sciences, Inc. Reports Third Quarter-End 2026 Financial Results
2026-11-12 16:00 · News Release
CV Sciences, Inc. To Announce Third Quarter 2026 Results On November 12, 2026
2026-11-05 17:00 · News Release
CV Sciences Welcomes Enactment of Federal Legislation Providing Additional Time for a Responsible, Science-Based Hemp Regulatory Framework
2026-09-08 17:00 · News Release
CV Sciences, Inc. Reports Second Quarter-End 2026 Financial Results
2026-08-13 16:00 · News Release
CV Sciences Launches PlusHLTH.com, Expanding Its Consumer Platform Beyond Cannabinoids
2026-08-11 22:30 · News Release
CV Sciences, Inc. to Announce Second Quarter 2026 Results on August 13, 2026
2026-08-10 20:00 · News Release
CV Sciences Expands +PlusHLTH(TM) Portfolio with Personalized Wellness Solutions for Healthy Aging
2026-06-25 20:00 · News Release
CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results
2026-05-14 16:00 · News Release
CV Sciences, Inc. To Announce First Quarter 2026 Results On May 14, 2026
2026-05-12 18:00 · News Release
CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results
2026-03-26 16:00 · News Release
Headlines only, with links to the full item. Company press releases are written by the company.

The financial report, and what it means

Annual figures to 2025-12-31
The report says
Revenue
$13,789,000
Net loss
($958,000)
What it means

It spends more than it earns

Under strain

Customers paid it $13.8 million in the year. It lost $958,000. For every $1 that came in, about $1.07 went out.

The report says
Cash and cash equivalents
$278,000
Net cash used in operating activities
($407,000)
What it means

The cash could run out soon

Under strain

It had $278,000 in the bank and used about $33,917 a month. At that pace the money lasts about 8 months unless it borrows or sells more shares.

The report says
Total assets
$6,962,000
Total liabilities
$5,494,000
What it means

It owns more than it owes

Steady

Everything the company owns adds up to $7 million. Its debts and unpaid bills add up to $5.5 million. That is about $0.79 owed for every $1 owned.

What this adds up to

2 of 3 checks show strain. It spends more than it earns. The cash could run out soon. These are facts from the company's own reports, not a recommendation.

Signals

Dilution2026-11-05

Shares outstanding rose from 184,263,663 (2025-11-11) to 242,184,128 (2026-11-05), up 31%.

Rule: Shares outstanding up 20% or more in 12 months. Source record

Estimated float2026-11-05

Estimated float about 210,094,491 shares as of 2026-11-05: 242,184,128 outstanding minus 32,089,637 held by 1 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Shares outstanding

Source: SEC filings
2025-12-31
184.3M
2026-03-24
193.5M
2026-03-31
193.5M
2026-05-11
204.0M
2026-06-30
213.1M
2026-08-11
225.8M
2026-09-30
235.7M
2026-11-05
242.2M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-11-16 4PRIMARY DOCUMENT
2026-11-13 10-Q10-Q
2026-11-12 8-K8-K
2026-10-26 8-K8-K
2026-09-09 SCHEDULE 13G
2026-09-09 3PRIMARY DOCUMENT
2026-09-09 4PRIMARY DOCUMENT
2026-08-13 8-K8-K
2026-08-13 10-Q10-Q
2026-06-04 8-K8-K
2026-05-15 10-Q10-Q
2026-05-14 8-K8-K

Common questions about CVSI

Does CVSI file reports with the SEC?

Yes. CV Sciences files with the SEC under company number 0001510964. The most recent filing we hold is a 4 dated 2026-11-16.

Source record

How many CVSI shares are outstanding?

242,184,128 shares as of 2026-11-05, as reported to the SEC. That is up 31% from 184,263,663 on 2025-11-11.

Source record

Has CVSI filed reports late?

We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.

Is CV Sciences making money?

Customers paid it $13.8 million in the year. It lost $958,000. For every $1 that came in, about $1.07 went out. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)

Source record